Charles River Laboratories is a leading Contract Research Organization (CRO) dedicated to improving global health by supporting pharmaceutical, biotechnology, and medical device companies in developing life-saving medicines and therapies.
Charles River Laboratories is a global Contract Research Organization (CRO) committed to "creating healthier lives." They provide critical research support to pharmaceutical, biotechnology, and medical device companies worldwide, collaborating with universities, research institutions, and government organizations. With decades of experience, Charles River offers a comprehensive portfolio of services, including research models, drug discovery and development support, safety assessment, and biologics testing. Their expertise helps clients expedite preclinical drug development, ensure product safety and quality, and bring novel therapies to market. As a leader in research models, they supply high-quality research animals and specialized models for basic research and discovery. Their integrated portfolio, backed by hundreds of scientists, employs advanced technology for chemistry, biology, and pharmacology services, supporting clients from early hit identification through investigational new drug (IND) applications. They also offer robust safety assessment services and regulatory guidance, conducting approximately 120 IND programs annually. Furthermore, Charles River provides extensive endotoxin testing, microbial detection, and identification solutions designed to meet industry needs and regulatory requirements. Their Biologics group, with over 50 years of experience, offers a wide range of services to address complex projects for biotechnology and pharmaceutical companies, supporting over 20,000 biologic testing reports and 200 licensed products each year.
About
**Who they are** Charles River Laboratories is a Contract Research Organization (CRO) focused on supporting pharmaceutical, biotechnology, and medical device companies. They aim to advance global health by aiding in the development of new medicines and therapies.
**Expertise & scope** - Support for the development of life-saving medicines and therapies. - Services for pharmaceutical, biotechnology, and medical device industries.
**Reputation / proof points** - Leading Contract Research Organization (CRO)
Additional information
Charles River Laboratories operates as a Contract Research Organization (CRO), providing essential support to companies in the pharmaceutical, biotechnology, and medical device sectors. Their primary mission is to contribute to global health by facilitating the development of innovative medicines and therapies. This involves a comprehensive approach to research and development support, enabling clients to bring critical healthcare solutions to market more effectively.
Key Highlights
Leading Contract Research Organization (CRO)
Source
“Charles River Laboratories is a leading Contract Research Organization (CRO)”
Certifications & Trust Signals
Established presence in the life sciences industry.
Source
“Founded in 1947, Charles River Laboratories has grown into a global leader.”
Buyer Snapshot
Best for
Pharmaceutical companies
Biotechnology companies
Medical device companies
How engagement typically works
Contract research support
Typical deliverables
Support for drug development
Therapy development assistance
Medical device development support
Good to know
Best when requiring specialized research and development support for life sciences products.
HQ: US
Languages: English
Status: listed
Services & Capabilities
Biocompatibility Testing (ISO 10993 Program)
Industries: Medical Devices
Iso10993 Standards Supported: ISO 10993-1, ISO 10993-5, ISO 10993-10, ISO 10993-11
Toxicology Capabilities: Comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to investigational new drugs (IND). Expedite their preclinical drug development with exceptional, comprehensive safety assessment services, state-of-the-art facilities, and expert regulatory guidance. Approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities each year. Provide a comprehensive portfolio of endotoxin testing, microbial detection, and microbial identification products and services. Biologics group provides a breadth of services that can address challenging projects for biotechnology and pharmaceutical companies worldwide. Support more than 20,000 biologic testing reports and over 200 licensed products each year.